A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
01/2003
01/01/2003	CN1097463C Method for preparing medicinal moxibustion materials extractive preparation for electrical moxibustion therapy
12/2002
12/31/2002	US6500438 In ovo vaccination against coccidiosis
12/31/2002	CA2227814C Substituted benzylaminopiperidine compounds
12/27/2002	WO2002102790A1 N-formyl hydroxylamine compounds as inhibitors of pdf
12/27/2002	WO2002102322A2 Stable cosmetic emulsion with polyamide gelling agent
12/27/2002	WO2002102308A2 Pharmaceutical composition for the treatment of viral infection
12/27/2002	WO2002102300A2 Diagnostics and therapeutics for glaucoma retinal degenerative diseases and cardiovascular diseases based on novel nucleic acid and protein forms of myocilin (myoc)
12/27/2002	WO2002069989A3 Aquatic animal treatment method and composition containing pimenta extract
12/27/2002	CA2519210A1 Stable cosmetic emulsion with polyamide gelling agent
12/27/2002	CA2448526A1 N-formyl hydroxylamine compounds as inhibitors of pdf
12/26/2002	US20020198407 Antiallergy agents and bronchodilators
12/26/2002	US20020198259 Treatment of disease caused by procedural vascular trauma and/or an increased level of plasma homocysteine
12/26/2002	US20020198257 Halogenated 2-phenyl-1,2-ethanediol monocarbamate derivatives
12/26/2002	US20020198239 Oxidizing 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl)thio)-1H -benzimidazole into S-omeprazole in an organic solvent, convering formed S-omeprazole into corresponding potassium salt by treating with potassium source
12/26/2002	US20020198229 Polymorphic form of clopidogrel hydrogen sulphate
12/26/2002	US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002	US20020198189 Treatment or prophylaxis of Semicarbazide-sensitive amine oxidase (SSAO) mediated complications in mammals including humans
12/26/2002	US20020198177 Coenzyme Q and EPA
12/26/2002	US20020198146 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts
12/25/2002	CN1387570A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for treatment of obesity
12/25/2002	CN1387531A Pyrazolo [4,3-d] pyrimidine derivs.
12/25/2002	CN1096862C Controlled-release dosage form of azithromycin
12/25/2002	CN1096853C Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
12/25/2002	CN1096847C Topical compositions comprising oil-in-water emulsion and retinoid
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	US6497905 Aqueous solubility pharmaceutical formulations
12/19/2002	WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002	WO2002100413A1 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- [4-(2-{4-METHANE SULFONYL OXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID OR 3-{4-[2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL} -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA
12/19/2002	WO2002100402A1 Compositions comprising nitrofurantoin and uva ursi
12/19/2002	WO2002100370A1 Breath protection microcapsules
12/19/2002	WO2002100322A2 Cosmetic composition for nails, free of phthalates, camphor and aromatic solvent
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193603 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
12/19/2002	US20020193601 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
12/19/2002	US20020193600 Preparing anhydrous 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha- dimethylbenzene acetic acid hydrochloride by azeotropic distillation of the corresponding hydrate
12/19/2002	US20020193589 Mercaptoacetylamide derivatives, a process for their preparation and their use
12/19/2002	US20020193317 Using smilagenin, prazerigenin, an astragaloside, tigogenin, ruscogenin, hecogenin and diosgenin in manufacture of medicament for therayp of condition characterised by deficiency in postsynaptic membrane-bound receptor number
12/19/2002	US20020193302 Use of FVIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
12/19/2002	US20020192312 Pharmaceutical compositions
12/19/2002	US20020192305 Inflammatory mediation obtained from atractylodes lancea
12/19/2002	US20020192172 Emulsions with naphthalate esters
12/19/2002	CA2449944A1 Compositions comprising nitrofurantoin and uva ursi
12/19/2002	CA2448763A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert- butoxy carbonyl aminophenyl)ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a sulonylurea
12/19/2002	CA2448543A1 Breath protection microcapsules
12/19/2002	CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/18/2002	EP1024786B1 Skin compatible hand cleanser, especially a course hand cleanser
12/18/2002	EP0948349B1 in vitro methods and use of pharmaceutical compositions for the TREATMENT OF INNER EAR HAIR CELLS
12/18/2002	EP0857055B1 Underarm compositions
12/18/2002	EP0804144B1 Solid protector against uv, process for its preparation and use thereof
12/18/2002	CN1096271C A procss for the preparation of pesticide-poor concentrates of active components of plants
12/17/2002	US6495606 Administering s-((r)-2-(1-iminoethylamino)propyl)-l-cysteine
12/17/2002	US6495541 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/17/2002	US6495528 Antiinflammatory agents; inhibiting leukocyte recruitment and activation; agonists of adenosine 2a receptor
12/17/2002	US6495525 N-((4-(((2-methylphenylamino)carbonyl)amino)phenyl)acetyl)-l -prolyl-3-methyl)-beta-alanine; very late antigen-4 cell adhesion inhibitor; inflammation and immune reactions
12/17/2002	CA2095223C Topical compositions for transdermal delivery of prodrug derivatives of morphine
12/17/2002	CA2083061C Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them
12/17/2002	CA2069153C Pharmaceutical composition
12/12/2002	WO2002098857A1 New indole derivatives with 5-ht6 receptor affinity
12/12/2002	WO2002061052A3 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
12/12/2002	US20020188029 Methods of treating or preventing weight gain, obesity, and related disorders
12/12/2002	US20020187994 New compounds
12/12/2002	US20020187958 Treatment of pain
12/12/2002	US20020187101 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes
12/11/2002	EP1264599A1 TNF-derived peptides for use in treating oedema
12/11/2002	EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer
12/11/2002	EP1263439A2 Sustained release ranolazine formulations
12/11/2002	EP1263409A1 Orally administered controlled delivery system for once daily administration of ciprofloxacin
12/11/2002	EP1263401A1 Oral composition comprising 2'-hydroxypropiophenone
12/11/2002	EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions
12/11/2002	EP0912110B1 Improvements in or relating to compositions containing creatine
12/11/2002	CN1384829A Sodium-hydrogen exchanger type 1 inhibitor crystals
12/11/2002	CN1384819A 前列腺素e类似物 E prostaglandin analogs
12/11/2002	CN1384755A Novel exendin agonist formulations and methods administration thereof
12/11/2002	CN1384749A Use of diphophonic acid in treatment of vasculogenesis
12/11/2002	CN1384738A Transdermal drug delivery devices
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/11/2002	CN1095657C Hand cleanser
12/10/2002	US6492539 Preparation of preparing substituted indanones
12/10/2002	US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002	US6492374 Benzofuran derivatives, their preparation and use
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492349 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
12/10/2002	US6491897 Solvent mixtures of water, ethanol and optionally isopropanol, propylene glycol and/or disodium ethylenediaminetetraacetate, containing drugs, used in inhalants; shelf life
12/10/2002	CA2234713C Underarm compositions
12/10/2002	CA2094533C Hydrocolloid wound gel
12/05/2002	WO2002097072A2 Influenza vaccine composition
12/05/2002	WO2002096909A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors
12/05/2002	WO2002096896A1 Biologically active methylene blue derivatives
12/05/2002	WO2002096879A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
12/05/2002	WO2002096865A1 Process for the preparation 3-aryl-2-hydroxypropionic acid derivative
12/05/2002	WO2002096453A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy)phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and insulin
12/05/2002	WO2002096435A2 Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
12/05/2002	WO2002096408A1 Coenzyme q and eicosapentaenoic acid (epa)
12/05/2002	WO2002096402A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a biguanide drug
12/05/2002	WO2002065978A3 Functional agent for decomposing nicotine and method of preparing the same
12/05/2002	WO2002028351A9 Recombinant mucin binding proteins from steptococcus pneumoniae
12/05/2002	US20020183396 Local anesthetic methods and kits
12/05/2002	US20020183356 Local anesthetic methods and kits
12/05/2002	CA2449199A1 Coenzyme q and eicosapentaenoic acid (epa)
12/05/2002	CA2448658A1 Process for the preparation 3-aryl-2-hydroxypropionic acid derivative

1 ... 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 ... 295